| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 06/12/2008 | DE112006001619T5 Kristalline Base von Escitalopram und orodispersible Tabletten, die Escitalopram-Base umfassen The crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| 06/12/2008 | DE102006058623A1 Oxooxetane als fungizide Mittel Oxooxetane as fungicidal agents |
| 06/12/2008 | CA2671179A1 Biphenyl-substituted spirocyclic ketoenols |
| 06/11/2008 | EP1930328A1 Cyano-containing polycyclic esters having lactone skeletons |
| 06/11/2008 | EP1928851A1 Vitamin d derivatives active on the vitamin d nuclear receptor, preparation and uses thereof |
| 06/11/2008 | EP1928599A2 Lewis acid catalyzed halogenation of activated carbon atoms |
| 06/11/2008 | EP1727809B1 Substituted morpholine and thiomorpholine derivatives |
| 06/11/2008 | EP1685121B1 Antidiabetic compounds comprising benzothiophene derivatives |
| 06/11/2008 | EP1485348B1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/11/2008 | CN101198598A Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 06/11/2008 | CN101195608A Method and device for separating 1,-butanediol |
| 06/11/2008 | CN101195599A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols |
| 06/11/2008 | CN100393709C Process for extracting tanshinone |
| 06/11/2008 | CN100393698C Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7384973 Materials and methods for treating hypercholesterolemia |
| 06/10/2008 | US7384962 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/10/2008 | US7384947 Treating cancer with anticarcinogenic agents 3-Amino-9-chloro-5,6,7,8-tetrahydro-naphtho[2,3-b]furan-2-yl))-(2-methyl-pyridin-3-yl)-methanone; antiproliferative agents |
| 06/10/2008 | US7384639 Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer molecule |
| 06/05/2008 | WO2008065522A2 Process for the synthesis of 4-difluoromethoxy-8-nitro-1-formyl dibenzo[b,d] furan-an intermediate for pde iv inhibitors |
| 06/05/2008 | US20080132714 Manufacture of Esters Using a Multiple Catalyst Approach |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132567 Alpha-Aminoamide Derivatives Useful in the Treatment of Lower Urinary Tract Disorders |
| 06/05/2008 | US20080132565 Polycyclic Macrolactones |
| 06/05/2008 | US20080132562 Tetronic and tetramic acids |
| 06/05/2008 | US20080132561 Materials and Methods for Treating Hypercholesterolemia |
| 06/05/2008 | US20080132507 Hydrazide Derivatives |
| 06/05/2008 | US20080132459 Inhibitors of Histone Deacetylase |
| 06/05/2008 | DE102006057036A1 New biphenyl substituted spirocyclic ketoenol derivatives useful for the manufacture of herbicides and for combating parasites |
| 06/04/2008 | EP1343775B1 Piperazine derivatives |
| 06/04/2008 | CN101193880A Exo- and diastereo- selective syntheses of himbacine analogs |
| 06/04/2008 | CN101193879A Catalytic preparation of cyclic carboxylic esters |
| 06/04/2008 | CN101193860A 有机化合物 Organic compounds |
| 06/04/2008 | CN101193852A Analogs of 4-hydroxyisoleucine and uses thereof |
| 06/04/2008 | CN101193631A Inhibitors of soluble adenylate cyclase |
| 06/04/2008 | CN101190912A Antiviral compound and preparation method thereof |
| 06/04/2008 | CN101190905A Preparation and application of N-(2,3-dihydro-2,4-dimethylbenzofuran-5-acyl)-N'-tert-butyl-N'-(substituted benzoyl)hydrazine insecticide |
| 06/04/2008 | CN101190904A Fatty acid synthetic enzyme inhibitor and medical preparation use thereof |
| 06/04/2008 | CN101190258A Total sesquiterpene lactone extract containing rich parthenolide and preparation method and application thereof |
| 06/04/2008 | CN100391953C Medicinal use and extraction of cis-ligusticum lactone |
| 06/04/2008 | CN100391952C Citalopram salt preparing and purifying process |
| 06/04/2008 | CN100391947C Biphenylcarboxamide compound |
| 06/04/2008 | CN100391928C Method for removing impurities from oxidation products |
| 06/03/2008 | US7381734 Serine protease inhibitors |
| 06/03/2008 | US7381719 To treat obesity and Related Diseases; oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; weight loss while maintaining or minimizing the loss of lean muscle mass; 6-[4-(2-Benzylamino-ethyl)-phenoxy]-nicotinamide |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 05/29/2008 | WO2008061400A1 Fatty acid synthase inhibitors and medical uses thereof |
| 05/29/2008 | US20080125482 Stabilized ascorbic acid solutions; method of use thereof; process for their obtention; and compositions comprising the same |
| 05/29/2008 | US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 05/29/2008 | US20080125412 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 05/29/2008 | US20080125345 Gamma-Undecenolactone, Method for the Preparation and Use Thereof for Cosmetics and in the Form of Food Additives |
| 05/29/2008 | US20080124577 Exhibits a light emission color with significantly high purity , highly efficient, highly luminant, and long-lived light emission; high glass transition temperature, heat stability and superior durability |
| 05/28/2008 | EP1924551A2 Organic compounds |
| 05/28/2008 | EP1768954A4 2-methylpropanamides and their use as pharmaceuticals |
| 05/28/2008 | EP1692123B1 Phenyl-furan compounds as vitamin d receptor modulators |
| 05/28/2008 | EP1577294A4 S-substituted n-1- (hetero)aryl alkyl-n - (hetero)aryl alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1- (hetero )aryl alkyl-n - (hetero)aryl alkylysothiocarbamides,a pharmaceutical compound and curing method |
| 05/28/2008 | EP1497028B1 Hydrogenation catalyst, preparation thereof, and method for the preparation of gamma-butyrolactone from maleic anhydride using the catalyst |
| 05/28/2008 | CN101189318A Reversibly thermochromic compositions |
| 05/28/2008 | CN101189220A Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| 05/28/2008 | CN101189219A Preventive or remedy for depression or anxiety neurosis |
| 05/28/2008 | CN101186598A 1-oxy-acetyl inula Britannica lactone derivative, preparation method thereof and application of the same in preparing cancer-curing medicine |
| 05/28/2008 | CN101186572A Method for separating and purifying salvianolic acid from red sage root liquid extract by one step |
| 05/28/2008 | CN100390178C Polycycloalkylpurines as adenosine receptor antagonists |
| 05/28/2008 | CN100390167C Total synthesis of myriaporones |
| 05/28/2008 | CN100390161C Hydroxy tanshinone IIA sodium sulfonate and its application |
| 05/28/2008 | CN100390160C Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/27/2008 | US7378548 Michael addition of an acrylic acid ester to a secondary amine such as diethanolamine; additives in chemical amplification photolithography giving photoresists with high resolution and excellent focus margin |
| 05/27/2008 | US7378535 Production of furanones |
| 05/27/2008 | US7378448 Diphenylether amide derivatives as opioid receptor antagonists |
| 05/27/2008 | US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 05/27/2008 | CA2303985C Method for producing phthalides |
| 05/22/2008 | WO2008059713A1 Fluoranthene compound, organic electroluminescent device using the fluoranthene compound, and organic electroluminescent material-containing solution |
| 05/22/2008 | WO2008059335A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 05/22/2008 | WO2008058402A1 Compounds and methods for treating protein folding disorders |
| 05/22/2008 | WO2007133414A3 Mercaptofunctional high 'mu-beta' ub eo chromophores and high tg, low optical loss, covalently bonded, polymers containing said chromophores and methods of synthesizing eo materials |
| 05/22/2008 | US20080119662 One Spot Synthesis of Citalopram from 5-Cyanophthalide |
| 05/22/2008 | US20080119661 Process for the preparation of N-monosubstituted beta-amino alcohols |
| 05/22/2008 | US20080119526 Ep2 receptor agonists |
| 05/22/2008 | US20080119485 Novel Benzofurans and Indols |
| 05/22/2008 | CA2668744A1 Compounds and methods for treating protein folding disorders |
| 05/21/2008 | EP1831191B1 Chroman derivatives and their use as 5-ht receptor ligands |
| 05/21/2008 | EP1603893B1 Ep4 receptor antagonists |
| 05/21/2008 | EP1562595B1 Diaryl ethers as opioid receptor antagonists |
| 05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |
| 05/21/2008 | EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 05/21/2008 | CN101184759A Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
| 05/21/2008 | CN101184744A Michael addition product and schiff's base aromachemicals |
| 05/21/2008 | CN101184743A Michael addition product and schiff's base aromachemicals |
| 05/21/2008 | CN101184726A 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 05/21/2008 | CN101184725A N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 05/21/2008 | CN101182316A Fixed bed reactor for producing maleic anhydride by benzene process with annual production capacity of 20 000 tons |
| 05/21/2008 | CN101182315A Substituted benzamido methyl formate compound as well as preparation method and uses thereof |
| 05/21/2008 | CN101182286A Stilbene group compounds as well as grape plant extractive containing the same and extraction method |
| 05/20/2008 | US7375252 Compounds and method for the inhibition of the expression of VCAM-1 |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375133 Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 05/20/2008 | US7375130 ethyl 3-[2-(4-chlorophenyl)-2-oxoethoxy]benzo[b]thiophene-2-carboxylate; non-insulin dependent diabetes, obesity, hypotensive agent; athrosclerosis, retinopathy |
| 05/20/2008 | US7375093 Nuclear receptor-based inducible gene expression system |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/15/2008 | WO2008057254A2 Tricyclic compounds as matrix metalloproteinase inhibitors |